Placeholder Image

字幕列表 影片播放

由 AI 自動生成
  • Dutch health technology company Phillips said on Monday it expected strong demand to continue into 2021 particularly for hospital equipment needed to treat Kovar 19 patients.

    荷蘭健康技術公司菲利普斯週一表示,預計強勁的需求將持續到2021年,特別是治療科華19號病人所需的醫院設備。

  • Phillips said both core earnings and comparable sales had increased 7% in the last three months of 2020.

    菲利普斯表示,在2020年的最後三個月,核心盈利和可比銷售額均增長了7%。

  • That was driven by a jump of almost a quarter in sales as it's connected care division, which supplies respiratory machines as well as monitoring and software platforms that allow remote care.

    這是由它的連接護理部門的銷售額躍升近四分之一所推動的,該部門提供呼吸機以及監測和軟件平臺,允許遠程護理。

  • Adjusted earnings rose to $1.39 billion between October and December.

    10月至12月,調整後的盈利上升至13.9億美元。

  • That continues the strong recovery underway in the previous quarter, when hospitals rushed to buy equipment to treat covert 19.

    這延續了上一季度的強勁復甦態勢,當時醫院急於購買設備治療隱性19。

  • But the company's CEO warned of some challenges.

    但該公司首席執行官警告說,存在一些挑戰。

  • A fresh wave of global infections is leading hospitals to delay elective procedures on the installation of new equipment in other areas.

    新一輪的全球感染浪潮正在導致醫院延後在其他地區安裝新設備的選擇性手術。

  • But he remained upbeat for the year ahead, saying orders were only pushed back and not canceled.

    但他對未來一年仍保持樂觀態度,稱訂單只是推後而非取消。

Dutch health technology company Phillips said on Monday it expected strong demand to continue into 2021 particularly for hospital equipment needed to treat Kovar 19 patients.

荷蘭健康技術公司菲利普斯週一表示,預計強勁的需求將持續到2021年,特別是治療科華19號病人所需的醫院設備。

字幕與單字
由 AI 自動生成

單字即點即查 點擊單字可以查詢單字解釋